HUSSMAN STRATEGIC MARKET CYCLE FUND HALO Holdings History
HUSSMAN STRATEGIC MARKET CYCLE FUND's Halozyme Therapeutics Inc Holding Summary
As of 2025-03-31, HUSSMAN STRATEGIC MARKET CYCLE FUND held 70,000.00 shares of Halozyme Therapeutics Inc(HALO), totaling $4.47 Mil. This investment constitutes 1.49% of their stock portfolio, and HUSSMAN STRATEGIC MARKET CYCLE FUND now holds 0.06% of the outstanding Halozyme Therapeutics Inc(HALO) stock.
The initial trade took place in 2022Q2. And since then HUSSMAN STRATEGIC MARKET CYCLE FUND has made 5 purchases of HALO, at an average price of $46.99, for a total of 91,000.00 shares. In addition, there have been 2 sales at an average price of $41.53 for 21,000.00 shares. Based on historical transaction data and HALO's current price of $55.92, HUSSMAN STRATEGIC MARKET CYCLE FUND's estimated gain on his HALO holdings is $510,090.00, reflecting a 11.93% gain to date.
HUSSMAN STRATEGIC MARKET CYCLE FUND HALO ($55.92) Holding Chart
HUSSMAN STRATEGIC MARKET CYCLE FUND HALO ($55.92) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
